AI-generated summary
This review gives an overview of clinical trials testing photobiomodulation therapy for acute radiodermatitis, a skin reaction caused by radiotherapy. The authors report that about seven trials have been performed, with results suggesting reduced severe skin reactions, less pain and better quality of life. They conclude there could be a strong recommendation for its use.
- Studies included
- 7
- Who or what was studied
- Cancer patients receiving radiotherapy who develop acute radiodermatitis
- Limits stated in the abstract
- The abstract does not report the size or design of the individual trials, and the authors' recommendation rests on the limited available evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.